Back to BlackRock, Inc.

PTCT
6 quarters

Position history for BlackRock, Inc.'s holdings in PTC THERAPEUTICS INC

BlackRock, Inc. holds 12.9M shares of PTCT (PTC THERAPEUTICS INC), worth $882.2M as of 2026-Q1. The position was increased (+1.3% shares). PTCT represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$882.2M

Current Shares

12.9M

Total Value Change

+$525.6M

Total Shares Change

+5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
12.9M
+1.3%
$882.2M0.0%$64.39
32
2025-Q4
Increased
12.8M
+79.2%
$970.7M0.0%$76.19
49
2025-Q3
Decreased
7.1M
-4.7%
$437.6M0.0%$60.65
0
2025-Q2
Decreased
7.5M
-3.7%
$365.3M0.0%$49.84
0
2025-Q1
Decreased
7.8M
-1.6%
$395.9M0.0%$54.24
0
2024-Q4
New
7.9M
-
$356.6M0.0%$45.77
43

Other major holders of PTCT: VANGUARD GROUP INC, RTW INVESTMENTS, LP, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used